Glasdegib is an orally administered drug that acts as a selective inhibitor of the Hedgehog pathway. This pathway is crucial in various cellular processes, including cell differentiation and tissue patterning. Aberrant activation of the Hedgehog pathway has been implicated in the pathogenesis of several cancers, particularly hematologic malignancies.
